vpr gene therapy (Theratechnologies)

N/A

Report date: 2026/01/27 10:14:06
NME

Base Information

Drug Namevpr gene therapy (Theratechnologies)
Drug Alias Namevpr gene therapy (Theratechnologies/Chiron)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionAntisense oligonucleotide inhibitors
TargetsUpdating
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTheratechnologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTheratechnologies IncChiron Corp
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A